NCT06060327View on ClinicalTrials.gov

Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section

NACompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

June 15, 2024

Conditions
Postpartum HemorrhageBlood Loss, PostoperativeCesarean Section Complications
Interventions
DRUG

Tranexamic acid

Giving oxytocin only, or oxytocin in addition to Tranexamic acid, Misoprostol or Carbetocin the mentioned doses and by the mention routes, then comparing the estimated blood loss in each group.

Trial Locations (2)

115431

kasr elainy hospital (Faculty of Medicine - Cairo University), Cairo

Unknown

Faculty of medicine - Cairo university, Cairo

All Listed Sponsors
lead

Cairo University

OTHER